These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8029903)

  • 21. Timing of splenectomy is critical in prolongation of cardiac xenografts.
    Araneda D; Carobbi A; Patselas T; Thomas F; Thomas J
    Transplant Proc; 1992 Apr; 24(2):523-4. PubMed ID: 1566415
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of a novel CD11b/CD18 inhibitory agent in a C6-deficient rat to evaluate delayed xenograft rejection.
    Johnson E; Leventhal J; Dalmasso A; Goswitz J; Simone P; Chen S; Moyle M; Matas A
    Transplant Proc; 1996 Apr; 28(2):728. PubMed ID: 8623367
    [No Abstract]   [Full Text] [Related]  

  • 23. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
    Xiao F; Shen J; Chong A; Liu W; Foster P; Blinder HL; Sankary H; McChesney L; Mital D; Williams JW
    Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348
    [No Abstract]   [Full Text] [Related]  

  • 24. Prolongation of cardiac xenograft survival by pre- and posttransplant splenectomy is associated with a decrease in anti-donor antibody titers.
    Quarantillo P; Araneda D; Thomas F; Thomas J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):387-8. PubMed ID: 8438347
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of the malononitrilamide X 920715 as compared with leflunomide in cardiac allo- and xenotransplantation in rats.
    Lin Y; Segers C; Waer M
    Transplant Proc; 1996 Dec; 28(6):3036. PubMed ID: 8962178
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunobiology of delayed xenograft rejection.
    Marquet RL; van Overdam K; Boudesteijn EA; Bonthuis F; Kouwenhoven EA; de Bruin RW; Schraa EO; IJzermans JN
    Transplant Proc; 1997; 29(1-2):955-6. PubMed ID: 9123605
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative immunopathologic study of hyperacute rejection in naive and sensitized rodent cardiac xenograft models.
    Wu GD; Cramer DV; Chapman FA; Wang HK; Chien K; Cole J; Makowka L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):464-5. PubMed ID: 8438380
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanisms involved in long-term hamster-to-rat cardiac xenograft survival.
    Lin Y; Vandeputte M; Waer M
    Transplant Proc; 1996 Apr; 28(2):683. PubMed ID: 8623343
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination therapy with FK 506 and splenectomy may induce tolerance in cardiac xenografts.
    Nishimori H; Suzuki S; Kido K; Tashiro H; Arita S; Ohdan H; Amemiya H
    Transplant Proc; 1994 Jun; 26(3):1064-6. PubMed ID: 7518102
    [No Abstract]   [Full Text] [Related]  

  • 30. Rejection of cardiac xenografts by CD4+ or CD8+ T cells.
    Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Anrather J; Bach FH
    J Immunol; 1999 Jan; 162(2):1206-14. PubMed ID: 9916754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experiments in cardiac xenotransplantation: fetal and neonatal exposure of graft recipients to xenogeneic cells.
    Mohiuddin M; Shen Z; Rostami S; DiSesa VJ
    Transplant Proc; 1994 Jun; 26(3):1306-7. PubMed ID: 8029916
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathogenesis and pathology of delayed xenograft rejection in pig-to-rhesus monkey cardiac transplantation.
    Chen D; Cao R; Guo H; Chen G; Wang X; Shen S; Chen S
    Transplant Proc; 2004 Oct; 36(8):2480-2. PubMed ID: 15561288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of tumor necrosis factor production in long-surviving concordant cardiac xenografts.
    Peterson SM; Noble BK; Gorfien J; Hoover EL; Bergsland J
    Transplant Proc; 1994 Jun; 26(3):1342-3. PubMed ID: 8029933
    [No Abstract]   [Full Text] [Related]  

  • 34. Timing of spleen activation in rats treated with cyclophosphamide (CyP): its role in a hamster-to-rat heterotopic heart xenotransplantation (HHX) model.
    Catena M; Lattanzio G; Maggiano N; Musiani P; Ferla G
    Transplant Proc; 1994 Jun; 26(3):1182-3. PubMed ID: 8029878
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyclosporine induces long-term xenograft survival in the mouse-to-C6-deficient rat heart transplantation model.
    Wu GS; Korsgren O; Tibell A
    Transplant Proc; 2000 Aug; 32(5):1015. PubMed ID: 10936325
    [No Abstract]   [Full Text] [Related]  

  • 36. The anticoagulant effect of antithrombin III on hyperacute xenograft rejection.
    Takeshita K; Arakawa K; Okamoto M; Akioka K; Fujiwara I; Kobayashi K; Imanishi J; Oka T
    Transplant Proc; 1996 Apr; 28(2):631-2. PubMed ID: 8623314
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined total lymphoid irradiation and cyclosporine promote xenograft survival.
    Knechtle SJ; Halperin EC; Bollinger RR
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1137-9. PubMed ID: 3274295
    [No Abstract]   [Full Text] [Related]  

  • 38. Delayed xenograft rejection in complement-depleted T-cell-deficient rat recipients of guinea pig cardiac grafts.
    Candinas D; Bach FH; Hancock WW
    Transplant Proc; 1996 Apr; 28(2):678. PubMed ID: 8623340
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimental cardiac xenografting with irradiation and intrathymic and intravenous xenogeneic cells.
    Mohiuddin M; Shen Z; Goldstein C; Yokoyama H; DiSesa VJ
    Transplant Proc; 1996 Apr; 28(2):673. PubMed ID: 8623337
    [No Abstract]   [Full Text] [Related]  

  • 40. Prolongation of xenograft survival by soluble complement receptor type 1 and antithrombin-III combination therapy.
    Fujiwara I; Nakajima H; Arakawa K; Akioka K; Takeshita K; Oka T
    Transplant Proc; 1996 Apr; 28(2):685-6. PubMed ID: 8623345
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.